Integrating Clinical Evaluation and Risk Management

Instructor: Daniel O Leary
Product ID: 701757
Training Level: Intermediate to Advanced
  • Duration: 90 Min
The webinar will discuss clinical evaluation, including the recommendations from MEDDEV 2.7-1 Clinical Evaluation: A Guide for Manufacturers and Notified Bodies. The training program will also cover MEDDEV 2.12-2 Guidelines on Post Market Clinical Follow-Up. Risk management, following EN ISO 14971: 2012, requires a risk management plan that includes activities related to collection and review of relevant production and post-production information. In this program, attendees will look at some approaches to write a post-production collection and review plan.

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: May-2016

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

Why Should You Attend:

In developing, manufacturing, and providing medical devices, risk management is an important aspect. In the EU, risk management utilizes the harmonized standard EN ISO 14971:2012. Based on ISO 14971:2007, risk management includes collecting and evaluating post-production information. If post-production information reveals unrecognized hazards, unrecognized hazardous situations, or risk estimates that are no longer acceptable, then the manufacturer reexamines the risk file and the associated decisions.

Clearly, much of the post-production information will update the clinical evaluation as well as the risk management file. This webinar will detail developing requirements and provide an integrated approach. Participants will receive a checklist to help implement the requirements.

Areas Covered in the Webinar:

  • Clinical evaluation requirements in the MDD
  • MEDDEV guidance documents and how to use them
  • Risk management requirements from EN ISO 14971:2012
  • The role of the risk management plan
  • Linking the sets of requirements to provide an efficient and comprehensive process

Who Will Benefit:

This webinar will provide information for people involved in risk management and clinical evaluation of medical devices. People in the following roles can especially benefit from the knowledge in this webinar:

  • Quality Managers
  • Regulatory Affairs Managers
  • Risk Managers
  • Management Representatives
  • Design Engineers
  • Notified Body Contacts

Instructor Profile:

Daniel O'Leary is president of Ombu Enterprises, LLC, a company offering training and execution in operational excellence, focused on analytic skills and a systems approach to operations management. Mr. O'Leary has more than 30 years’ experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Master’s Degree in Mathematics; is an ASQ certified biomedical auditor, quality auditor, quality engineer, reliability engineer, and Six Sigma Black Belt; and certified by APICS in resource management.

Topic Background:

Medical devices sold in the European Union fall under the Medical Device Directive (MDD). The Essential Requirements in Annex I paragraph 6a says, “Demonstration of conformity with the essential requirements must include a clinical evaluation in accordance with Annex X.” This applies to all devices, regardless of class.

Annex X, section 1.1c, requires the manufacturer to update the clinical evaluation and its documentation using data obtained from post-market surveillance. This doesn’t specify the method, but does refer to a post-market surveillance plan for the device.

Follow us :
Biocompatibility Testing for Medical Devices
Internal Audit, Fraud Risk Assessment and Risk Management Annual Plan

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed